Pharma Stock Quotes

No,” said a third student. “Novartis is a public company. It’s not the boss or the board who decides. It’s the shareholders. If the board changes its priorities the shareholders will just elect a new board.” “That’s right,” I said. “It’s the shareholders who want this company to spend their money on researching rich people’s illnesses. That’s how they get a good return on their shares.” So there’s nothing wrong with the employees, the boss, or the board, then. “Now, the question is”—I looked at the student who had first suggested the face punching—“who owns the shares in these big pharmaceutical companies?” “Well, it’s the rich.” He shrugged. “No. It’s actually interesting because pharmaceutical shares are very stable. When the stock market goes up and down, or oil prices go up and down, pharma shares keep giving a pretty steady return. Many other kinds of companies’ shares follow the economy—they do better or worse as people go on spending sprees or cut back—but the cancer patients always need treatment. So who owns the shares in these stable companies?” My young audience looked back at me, their faces like one big question mark. “It’s retirement funds.” Silence. “So maybe I don’t have to do any punching, because I will not meet the shareholders. But you will. This weekend, go visit your grandma and punch her in the face. If you feel you need someone to blame and punish, it’s the seniors and their greedy need for stable stocks.

Today, Pharma still regards Africa as the beau ideal to test immunizations, and as a lucrative receptacle for dumping expired and defective stocks.5 Bill Gates has played a key role in legitimizing this arrangement while collaborating with captive or corrupt WHO officials to scam Western donor nations into footing the bill, and guaranteeing rich profits for pharmaceutical companies in which, coincidentally, he holds hefty stock positions. Gates—the “biggest funder of vaccines in the world”6—is heavily invested in lucrative partnerships with almost all the world’s largest vaccine companies.7 Bill and Melinda Gates have continued the tradition of human experimentation in Africa with the WHO stepping neatly into the role of an enabling colonial vassal.

Rockefeller’s success promoting the eugenics movement had already captivated Adolf Hitler. “Now that we know the laws of heredity,” Hitler told a fellow Nazi, “it is possible to a large extent to prevent unhealthy and severely handicapped beings from coming into the world. I have studied with interest the laws of several American states concerning prevention of reproduction by people whose progeny would, in all probability, be of no value or be injurious to the racial stock.”52

Gates Foundation currently holds corporate stocks and bonds in drug companies like Merck, GSK, Eli Lilly, Pfizer, Novartis, and Sanofi.69 Gates also has heavy positions in Gilead, Biogen, AstraZeneca, Moderna, Novavax, and Inovio. The foundation’s website candidly declares its mission to “seek more effective models of collaboration with major vaccine manufacturers to better identify and pursue mutually beneficial opportunities.

First of all, there are tremendous financial and social interests involved. Billions of dollars in research funding, stock options, and activist budgets are predicated on the assumption that HIV causes AIDS. Entire industries of pharmaceutical drugs, diagnostic testing, and activist causes would have no reason to exist.

Not only was the drug developed with taxpayer money, but its $712 per dose price to the taxpayer is forty times more than Merck’s $17.64 cost of production. Merck, which expects to make $7 billion per year on the new blockbuster, saw its stock price spike on news of the government contract and after President Biden’s televised plug.

On June 9, 2021 President Biden dutifully reiterated the US government’s commitment to procure approximately 1.7 million courses of the NIAID-funded drug from Merck.81 BARDA collaborated with a confederacy of other shady Defense Department operatives, including the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the Army Contracting Command, on the $1.2 billion purchase. Not only was the drug developed with taxpayer money, but its $712 per dose price to the taxpayer is forty times more than Merck’s $17.64 cost of production. Merck, which expects to make $7 billion per year on the new blockbuster, saw its stock price spike on news of the government contract and after President Biden’s televised plug.

The story, of course, was fraud. Days later, Oklahoma’s Sequoyah Northeastern Health System posted a categorical denial on its website, dismissing the entire story as mere fabrication. That Rolling Stone picture of the long lines was an Associated Press stock photo from the previous January, a photo of people waiting in line to get vaccines. As it turns out, not a single patient has been treated in Oklahoma for ivermectin overdose.

Pharmaceutical Syrup Manufacturers Saphnix Life Sciences is an emerging and fastest-growing Pharmaceutical Syrup Manufacturers. Our company is well based in Chandigarh and popular for its best high-quality wide range of Syrup range. We the best Syrup Range Manufacturer in India are capable of carrying out large-scale manufacturing and supplying various varieties of syrups/suspension ranges to many pharma companies all around India. WE FOLLOW THE LATEST AND MOST ADVANCED SYRUP MANUFACTURING TOOLS Our company has built its modern, fully developed infrastructure. Maximum possible use of technology and sources lead us to manufacture medicines cost-effectively. To obtain pure, safe, and non-contaminated medicines, we use sterilized machinery to manufacture and package the medicines. The company is using all the quality methods for syrup/suspension manufacturing. Different manufacturing tools for syrup include- 1. Control Panel 2. Product Piping 3. Storage Vessel 4. Working Platform 5. Sugar Syrup Vessel 6. Manufacturing Vessel Salient Features In addition to the above, you can also choose us for these reasons: • -On-time delivery • -Year around stock availability • -24*7 customer support • -Quality medicinal drugs • -Appealing packaging Saphnix Lifesciences: Proudly the best Pharmaceutical Syrup manufacturer in India.

Billionaires have had a terrific pandemic. Central banks pumped trillions of dollars into financial markets to save the economy, yet much of that has ended up lining the pockets of billionaires riding a stock market boom. Vaccines were meant to end this pandemic, yet rich governments allowed pharma billionaires and monopolies to cut off the supply to billions of people. The result is that every kind of inequality imaginable risks rising. The predictability of it is sickening. The consequences of it kill.

We live in a world where cures are not what Big Pharma is putting their research dollars into, nor are budgets allocated to “un patent-able” molecules like melatonin. What they prefer is a long-term dosing schedule that keeps the dollars rolling in, stock price up, and the shareholders happy. If you’re looking for a miraculous compound that can heal, cure, and prevent disease, you found it with melatonin.